FI101194B1 - Menetelmä stabiloidun, gonadotropiinia sisältävän lyofilisaatin valmistamiseksi - Google Patents
Menetelmä stabiloidun, gonadotropiinia sisältävän lyofilisaatin valmistamiseksiInfo
- Publication number
- FI101194B1 FI101194B1 FI911309A FI911309A FI101194B1 FI 101194 B1 FI101194 B1 FI 101194B1 FI 911309 A FI911309 A FI 911309A FI 911309 A FI911309 A FI 911309A FI 101194 B1 FI101194 B1 FI 101194B1
- Authority
- FI
- Finland
- Prior art keywords
- preparations
- lyophilized
- dicarboxylic acid
- disclosed
- lyophilate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90200665 | 1990-03-20 | ||
EP90200665 | 1990-03-20 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI911309A0 FI911309A0 (fi) | 1991-03-18 |
FI911309A FI911309A (fi) | 1991-09-21 |
FI101194B1 true FI101194B1 (fi) | 1998-05-15 |
FI101194B FI101194B (fi) | 1998-05-15 |
Family
ID=8204967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI911309A FI101194B (fi) | 1990-03-20 | 1991-03-18 | Menetelmä stabiloidun, gonadotropiinia sisältävän lyofilisaatin valmis tamiseksi |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0448146B1 (fi) |
JP (1) | JP3031570B2 (fi) |
KR (1) | KR100221123B1 (fi) |
AT (1) | ATE107172T1 (fi) |
AU (1) | AU631730B2 (fi) |
CA (1) | CA2037884C (fi) |
DE (1) | DE69102465T2 (fi) |
DK (1) | DK0448146T3 (fi) |
ES (1) | ES2057731T3 (fi) |
FI (1) | FI101194B (fi) |
HK (1) | HK1002494A1 (fi) |
ID (1) | ID905B (fi) |
IE (1) | IE64738B1 (fi) |
NZ (1) | NZ237458A (fi) |
PT (1) | PT97074B (fi) |
ZA (1) | ZA911659B (fi) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
AU679986B2 (en) * | 1993-04-28 | 1997-07-17 | N.V. Organon | Lyospheres comprising gonadotropin |
JP4165878B2 (ja) * | 1993-06-03 | 2008-10-15 | 株式会社林原生物化学研究所 | トレハロース遊離酵素とその製造方法並びに用途 |
US5556771A (en) * | 1995-02-10 | 1996-09-17 | Gen-Probe Incorporated | Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification |
DK0814841T3 (da) * | 1995-03-21 | 2002-03-04 | Applied Research Systems | Flydende hCG-formuleringer |
IL120202A (en) | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
NZ508874A (en) * | 1998-07-23 | 2004-03-26 | Lilly Co Eli | FSH and FSH variant formulations, products and methods of treating infertility. |
US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
TWI277425B (en) | 1999-04-13 | 2007-04-01 | Lilly Co Eli | Pulmonary administration of dry powder formulations for treating infertility |
AU2002210749B2 (en) * | 2000-10-31 | 2006-12-21 | Pharma Mar, S.A. | Kahalalide F formulation |
EP1356809A4 (en) * | 2000-12-28 | 2008-05-14 | Takeda Pharmaceutical | Sustained release preparations |
GB0207092D0 (en) * | 2002-03-26 | 2002-05-08 | Sod Conseils Rech Applic | Stable pharmaceutical composition containing factor VIII |
KR101105486B1 (ko) * | 2003-04-02 | 2012-01-13 | 아레스 트레이딩 에스.에이. | Fsh 및 lh과 비이온성 계면활성제의 액상 약제학적 제제 |
US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
EP1638595B1 (en) | 2003-06-20 | 2013-03-20 | Ares Trading S.A. | Freeze-dried fsh / lh formulations |
DE10333317A1 (de) * | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
SG151298A1 (en) | 2004-04-08 | 2009-04-30 | Biomatrica Inc | Integration of sample storage and sample management for life science |
WO2007095337A2 (en) * | 2006-02-15 | 2007-08-23 | Imclone Systems Incorporated | Antibody formulation |
NZ583991A (en) | 2007-11-01 | 2012-02-24 | Merck Serono Sa | Luteinizing hormone liquid formulations |
CN101269215B (zh) * | 2008-05-15 | 2011-03-23 | 上海天伟生物制药有限公司 | 一种糖蛋白激素组合物 |
CA2761675A1 (en) | 2009-05-11 | 2010-11-18 | Biomatrica, Inc. | Compositions and methods for biological sample storage |
EP2598660B1 (en) | 2010-07-26 | 2017-03-15 | Biomatrica, INC. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
CA2806734A1 (en) | 2010-07-26 | 2012-02-09 | Biomatrica, Inc. | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
BR112013011041B1 (pt) | 2010-11-05 | 2021-05-25 | Baxalta GmbH | variante de fator viii, método para produzir uma variante de fviii, uso da variante de fator viii, e, composição farmacêutica |
CN102293756A (zh) * | 2011-08-24 | 2011-12-28 | 蚌埠丰原涂山制药有限公司 | 一种尿促性素冻干粉针剂及其制备方法 |
US8609820B2 (en) | 2011-10-28 | 2013-12-17 | Neotope Biosciences Limited | Humanized antibodies that recognize alpha-synuclein |
MY171140A (en) | 2012-01-27 | 2019-09-27 | Prothena Biosciences Ltd | Humanized antibodies that recognize alpha-synuclein |
UA118441C2 (uk) | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
WO2014100755A2 (en) | 2012-12-20 | 2014-06-26 | Biomatrica, Inc. | Formulations and methods for stabilizing pcr reagents |
US10513555B2 (en) | 2013-07-04 | 2019-12-24 | Prothena Biosciences Limited | Antibody formulations and methods |
JP6661554B2 (ja) | 2014-06-10 | 2020-03-11 | バイオマトリカ,インク. | 周囲温度における血小板の安定化 |
KR102589056B1 (ko) | 2015-12-08 | 2023-10-12 | 바이오매트리카 인코포레이티드 | 적혈구 침강 속도의 감소 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932943A (en) * | 1970-08-14 | 1976-01-20 | E. I. Du Pont De Nemours And Company | Method of preparation of lyophilized biological products |
IT1057895B (it) * | 1975-02-17 | 1982-03-30 | Serono Lab | Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione |
DE3467706D1 (en) * | 1983-04-28 | 1988-01-07 | Armour Pharma | Pharmaceutical preparation containing purified fibronectin |
GB8604983D0 (en) * | 1986-02-28 | 1986-04-09 | Biocompatibles Ltd | Protein preservation |
US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
-
1991
- 1991-03-05 IE IE73291A patent/IE64738B1/en not_active IP Right Cessation
- 1991-03-06 DK DK91200483.5T patent/DK0448146T3/da active
- 1991-03-06 ZA ZA911659A patent/ZA911659B/xx unknown
- 1991-03-06 DE DE69102465T patent/DE69102465T2/de not_active Expired - Lifetime
- 1991-03-06 EP EP91200483A patent/EP0448146B1/en not_active Expired - Lifetime
- 1991-03-06 ES ES91200483T patent/ES2057731T3/es not_active Expired - Lifetime
- 1991-03-06 AT AT91200483T patent/ATE107172T1/de not_active IP Right Cessation
- 1991-03-08 CA CA002037884A patent/CA2037884C/en not_active Expired - Lifetime
- 1991-03-18 NZ NZ237458A patent/NZ237458A/en unknown
- 1991-03-18 FI FI911309A patent/FI101194B/fi active
- 1991-03-19 AU AU73623/91A patent/AU631730B2/en not_active Expired
- 1991-03-19 JP JP3054865A patent/JP3031570B2/ja not_active Expired - Lifetime
- 1991-03-19 KR KR1019910004303A patent/KR100221123B1/ko not_active IP Right Cessation
- 1991-03-19 PT PT97074A patent/PT97074B/pt not_active IP Right Cessation
-
1992
- 1992-01-31 ID IDP219492A patent/ID905B/id unknown
-
1998
- 1998-02-11 HK HK98101030A patent/HK1002494A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI911309A (fi) | 1991-09-21 |
PT97074B (pt) | 1998-10-30 |
ES2057731T3 (es) | 1994-10-16 |
JPH04217630A (ja) | 1992-08-07 |
DE69102465T2 (de) | 1995-03-02 |
KR100221123B1 (ko) | 1999-09-15 |
ATE107172T1 (de) | 1994-07-15 |
CA2037884C (en) | 2003-10-21 |
ID905B (id) | 1996-09-10 |
ZA911659B (en) | 1991-12-24 |
FI911309A0 (fi) | 1991-03-18 |
IE910732A1 (en) | 1991-09-25 |
EP0448146B1 (en) | 1994-06-15 |
JP3031570B2 (ja) | 2000-04-10 |
AU7362391A (en) | 1991-09-26 |
EP0448146A1 (en) | 1991-09-25 |
CA2037884A1 (en) | 1991-09-21 |
FI101194B (fi) | 1998-05-15 |
HK1002494A1 (en) | 1998-08-28 |
DE69102465D1 (de) | 1994-07-21 |
AU631730B2 (en) | 1992-12-03 |
DK0448146T3 (da) | 1994-10-24 |
KR910016340A (ko) | 1991-11-05 |
NZ237458A (en) | 1992-02-25 |
IE64738B1 (en) | 1995-09-06 |
PT97074A (pt) | 1991-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI101194B1 (fi) | Menetelmä stabiloidun, gonadotropiinia sisältävän lyofilisaatin valmistamiseksi | |
DE69232847T2 (de) | Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält | |
TR199800062A2 (xx) | S�v� gonadotropin ihtiva eden form�lasyonlar. | |
US6117984A (en) | Growth hormone crystals and a process for production of these GH-crystals | |
RU98100930A (ru) | Жидкие композиции, содержащие гонадотропин | |
EP0355460A3 (en) | Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization | |
DE3881281T2 (de) | Stabilisierter attenuierter lebender impfstoff und seine herstellung. | |
JP3702313B2 (ja) | ゴナドトロピン含有薬剤組成物 | |
KR970706841A (ko) | 성장호르몬 및 루신으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and leucine) | |
IL86638A0 (en) | (2-cyano-2-oximinoacetyl)-amino acid derivatives,their preparation and their use as pesticides | |
DE59008754D1 (de) | Verfahren zur Herstellung von granuliertem Natriumacetat-Trihydrat. | |
KR950704494A (ko) | 수두-대상포진 바이러스(vzv)에 대한 백신(vaccines against varicellazoster virus(vzv)) | |
TH23071B (th) | สูตรผสมของเหลวที่มีโกนาโดโทรพิน | |
JPS643160A (en) | (2-cyano-2-oxyiminoacetyl)-amino acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: N.V. ORGANON Free format text: N.V. ORGANON |